1. Cen, Zhidong, Chen, You, Chen, Si, Zhang, Baorong, Luo, Wei. . Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification. In Brain : a journal of neurology, 143, 491-502. doi:10.1093/brain/awz392. https://pubmed.ncbi.nlm.nih.gov/31851307/
2. Schottlaender, Lucia V, Abeti, Rosella, Jaunmuktane, Zane, Aurrand-Lions, Michel, Houlden, Henry. . Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification. In American journal of human genetics, 106, 412-421. doi:10.1016/j.ajhg.2020.02.007. https://pubmed.ncbi.nlm.nih.gov/32142645/
3. Chen, Jun, Cui, Yuan, Chen, Zhimeng, Zhao, Jun, Tong, Xin. . Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma. In Cancer reports (Hoboken, N.J.), 8, e70038. doi:10.1002/cnr2.70038. https://pubmed.ncbi.nlm.nih.gov/39838844/
4. Dong, Yanxin, Zhang, Jiale, Xie, Shun, Fan, Boshi, Gong, Taiqian. . JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma. In The journal of gene medicine, 26, e3679. doi:10.1002/jgm.3679. https://pubmed.ncbi.nlm.nih.gov/38404047/
5. Peng, Yang, Li, Han, Fu, Yong, Zong, Beige, Liu, Shengchun. 2021. JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer. In International immunopharmacology, 103, 108430. doi:10.1016/j.intimp.2021.108430. https://pubmed.ncbi.nlm.nih.gov/34923424/
6. Marinho, Waydja L V A, de Oliveira, João Ricardo M. 2021. JAM2: A New Culprit at the Pathophysiology of Primary Familial Brain Calcification. In Journal of molecular neuroscience : MN, 71, 1723-1724. doi:10.1007/s12031-021-01816-8. https://pubmed.ncbi.nlm.nih.gov/33743113/
7. Kiyama, Takae, Altay, Halit Y, Badea, Tudor C, Mao, Chai-An. 2023. Pou4f1-Tbr1 transcriptional cascade controls the formation of Jam2-expressing retinal ganglion cells. In Frontiers in ophthalmology, 3, . doi:10.3389/fopht.2023.1175568. https://pubmed.ncbi.nlm.nih.gov/38469155/
智鼠故事 
